{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:14:14Z","timestamp":1793060054718,"version":"4.5.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2018.00005","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T04:33:55Z","timestamp":1517459635000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":69,"title":["Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose"],"prefix":"10.3389","volume":"5","author":[{"given":"Jens","family":"Dreier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius","family":"Knabbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/tme.12405","article-title":"Hepatitis E: the current state of play","volume":"27","author":"Ankcorn","year":"2017","journal-title":"Transfus Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/trf.13976","article-title":"Hepatitis E risks: pigs or blood-that is the question","volume":"57","author":"Tedder","year":"2017","journal-title":"Transfusion"},{"key":"B3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-94-024-0942-0_10","article-title":"Clinical manifestations of hepatitis E","volume":"948","author":"Xin","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.tracli.2017.06.012","article-title":"HEV and transfusion-recipient risk","volume":"24","author":"Izopet","year":"2017","journal-title":"Transfus Clin Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000357098","article-title":"Autochthonous hepatitis E virus infections: a new transfusion-associated risk?","volume":"41","author":"Dreier","year":"2014","journal-title":"Transfus Med Hemother"},{"key":"B6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000031215","article-title":"Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E","volume":"79","author":"Arankalle","year":"2000","journal-title":"Vox Sang"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/1560-7917.ES.2017.22.16.30514","article-title":"Hepatitis E and blood donation safety in selected European countries: a shift to screening?","volume":"22","author":"Domanovi\u0107","year":"2017","journal-title":"Euro Surveill"},{"key":"B8","first-page":"4353","article-title":"European Pharmacopeia Chapter 8.3: Human plasma (pooled and treated for virus inactivation)","year":"2014","journal-title":"Eur Pharmacopoeia"},{"key":"B9","unstructured":"Reflection Paper on Viral Safety of Plasma-Derived Medicinal Products with Respect to Hepatitis E Virus2015"},{"key":"B10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000118792","article-title":"Prevalence of hepatitis E virus IgG antibody in Japanese patients with hemophilia","volume":"51","author":"Toyoda","year":"2008","journal-title":"Intervirology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/trf.13978","article-title":"Cost-effectiveness of the screening of blood donations for hepatitis E virus in the Netherlands","volume":"57","author":"de Vos","year":"2017","journal-title":"Transfusion"},{"key":"B12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000431191","article-title":"Hepatitis E virus","volume":"42","author":"Pauli","year":"2015","journal-title":"Transfus Med Hemother"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1128\/JCM.01119-12","article-title":"Novel approach for the detection of hepatitis E virus infection in German blood donors","volume":"50","author":"Vollmer","year":"2012","journal-title":"J Clin Microbiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1111\/trf.13700","article-title":"Low transfusion transmission of hepatitis E among 25,637 single-donation, nucleic acid-tested blood donors","volume":"56","author":"Harritsh\u00f8j","year":"2016","journal-title":"Transfusion"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1111\/trf.13757","article-title":"Hepatitis E virus infection in the Irish blood donor population","volume":"56","author":"O\u2019Riordan","year":"2016","journal-title":"Transfusion"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.3201\/eid2011.140516","article-title":"Hepatitis E virus infections in blood donors, France","volume":"20","author":"Gallian","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/trf.12929","article-title":"Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain)","volume":"55","author":"Sauleda","year":"2015","journal-title":"Transfusion"},{"key":"B18","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/trf.13402","article-title":"Incidence and duration of hepatitis E virus infection in Dutch blood donors","volume":"56","author":"Hogema","year":"2016","journal-title":"Transfusion"},{"key":"B19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1128\/CMR.00057-13","article-title":"Hepatitis E virus infection","volume":"27","author":"Kamar","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S1473-3099(08)70255-X","article-title":"Hepatitis E: an emerging infection in developed countries","volume":"8","author":"Dalton","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jhep.2007.12.008","article-title":"Hepatitis E: an emerging awareness of an old disease","volume":"48","author":"Purcell","year":"2008","journal-title":"J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/1560-7917.ES.2016.21.35.30332","article-title":"Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011","volume":"21","author":"Vollmer","year":"2016","journal-title":"Euro Surveill"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.jhep.2012.08.001","article-title":"Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity","volume":"57","author":"Ha\u00efm-Boukobza","year":"2012","journal-title":"J Hepatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","article-title":"Hepatitis E virus in blood components: a prevalence and transmission study in southeast England","volume":"384","author":"Hewitt","year":"2014","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/j.1440-1746.2004.03437.x","article-title":"Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area","volume":"19","author":"Khuroo","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2169\/internalmedicine.54.2332","article-title":"Late onset post-transfusion hepatitis E developing during chemotherapy for acute promyelocytic leukemia","volume":"54","author":"Fuse","year":"2015","journal-title":"Intern Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/jmv.20215","article-title":"Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion","volume":"74","author":"Mitsui","year":"2004","journal-title":"J Med Virol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1872-034X.2007.00024.x","article-title":"Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma","volume":"37","author":"Tamura","year":"2007","journal-title":"Hepatol Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/trf.13994","article-title":"Unique clinical courses of transfusion-transmitted hepatitis E in patients with immunosuppression","volume":"57","author":"Satake","year":"2017","journal-title":"Transfusion"},{"key":"B30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/vox.12156","article-title":"Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma","volume":"107","author":"Andonov","year":"2014","journal-title":"Vox Sang"},{"key":"B31","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/j.1537-2995.2004.03300.x","article-title":"Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan","volume":"44","author":"Matsubayashi","year":"2004","journal-title":"Transfusion"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1111\/j.1537-2995.2008.01722.x","article-title":"A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route","volume":"48","author":"Matsubayashi","year":"2008","journal-title":"Transfusion"},{"key":"B33","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/hepr.12390","article-title":"Rare case of transfusion-transmitted hepatitis E from the blood of a donor infected with the hepatitis E virus genotype 3 indigenous to Japan: viral dynamics from onset to recovery","volume":"45","author":"Matsui","year":"2015","journal-title":"Hepatol Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3201\/eid1304.061387","article-title":"Transfusion-associated hepatitis E, France","volume":"13","author":"Colson","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-3148.2006.00652.x","article-title":"Transfusion-transmitted hepatitis E in a \u2018nonhyperendemic\u2019 country","volume":"16","author":"Boxall","year":"2006","journal-title":"Transfus Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2450\/2013.0081-13","article-title":"Transfusion-transmitted hepatitis E in a patient with myelodysplastic syndromes","volume":"12","author":"Kimura","year":"2014","journal-title":"Blood Transfus"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.2169\/internalmedicine.55.7025","article-title":"Chronic hepatitis E infection in a persistently immunosuppressed patient unable to be eliminated after ribavirin therapy","volume":"55","author":"Miyoshi","year":"2016","journal-title":"Intern Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.ebiom.2015.09.030","article-title":"A nationwide survey of hepatitis E virus infection and chronic hepatitis E in liver transplant recipients in Japan","volume":"2","author":"Inagaki","year":"2015","journal-title":"EBioMedicine"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/hepr.12641","article-title":"Treatment with ribavirin for chronic hepatitis E following living donor liver transplantation: a case report","volume":"46","author":"Tanaka","year":"2016","journal-title":"Hepatol Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1182\/blood-2013-09-524348","article-title":"Hepatitis E transmission by transfusion of Intercept blood system-treated plasma","volume":"123","author":"Hauser","year":"2014","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1097\/TP.0b013e318296c9f7","article-title":"Posttransplantation hepatitis E: transfusion-transmitted hepatitis rising from the ashes","volume":"96","author":"Coilly","year":"2013","journal-title":"Transplantation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/1560-7917.ES2014.19.21.20812","article-title":"Transfusion-transmitted hepatitis E in Germany, 2013","volume":"19","author":"Huzly","year":"2014","journal-title":"Euro Surveill"},{"key":"B43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40792-016-0159-0","article-title":"Chronic hepatitis E virus infection after living donor liver transplantation via blood transfusion: a case report","volume":"2","author":"Kurihara","year":"2016","journal-title":"Surg Case Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5694\/mja16.01090","article-title":"First confirmed case of transfusion-transmitted hepatitis E in Australia","volume":"206","author":"Hoad","year":"2017","journal-title":"Med J Aust"},{"key":"B45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/trf.13876","article-title":"Red blood cell transfusion-transmitted acute hepatitis E in an immunocompetent subject in Europe: a case report","volume":"57","author":"Riveiro-Barciela","year":"2017","journal-title":"Transfusion"},{"key":"B46","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/cid\/ciw309","article-title":"Blood-borne hepatitis E virus transmission: a relevant risk for immunosuppressed patients","volume":"63","author":"Pischke","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B47","unstructured":"Haemovigilance report of the Paul-Ehrlich-Institut 2015: Assessment of the reports of serious adverse transfusion reactions pursuant to section 63i AMG (Arzneimittelgesetz, German Medicines Act)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1073\/pnas.1018878108","article-title":"Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant","volume":"108","author":"Shukla","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B49","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1099\/vir.0.82535-0","article-title":"Development and evaluation of an efficient cell-culture system for hepatitis E virus","volume":"88","author":"Tanaka","year":"2007","journal-title":"J Gen Virol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1128\/JCM.00629-09","article-title":"Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5\/15F strain recovered from a fulminant hepatitis patient","volume":"47","author":"Tanaka","year":"2009","journal-title":"J Clin Microbiol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.1128\/JVI.00146-12","article-title":"Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination","volume":"86","author":"Shukla","year":"2012","journal-title":"J Virol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.0042-9007.2004.00377.x","article-title":"Transfusion of plasma from a blood donor induced hepatitis E in Rhesus monkey","volume":"86","author":"Xia","year":"2004","journal-title":"Vox Sang"},{"key":"B53","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.antiviral.2017.02.011","article-title":"Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma","volume":"141","author":"Sayed","year":"2017","journal-title":"Antiviral Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1136\/gutjnl-2015-311109","article-title":"Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver","volume":"66","author":"Sayed","year":"2017","journal-title":"Gut"},{"key":"B55","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/trf.13889","article-title":"Comparison of hepatitis E virus nucleic acid test screening platforms and RNA prevalence in French blood donors","volume":"57","author":"Gallian","year":"2017","journal-title":"Transfusion"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1128\/JCM.03578-13","article-title":"Comparison of real-time PCR and antigen assays for detection of hepatitis E virus in blood donors","volume":"52","author":"Vollmer","year":"2014","journal-title":"J Clin Microbiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1159\/000450794","article-title":"Knowledge is safety: the time is ripe for hepatitis E virus blood donor screening","volume":"43","author":"Vollmer","year":"2016","journal-title":"Transfus Med Hemother"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2018.00005\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T13:13:05Z","timestamp":1526389985000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2018.00005\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":57,"alternative-id":["10.3389\/fmed.2018.00005"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2018.00005","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,1]]},"article-number":"5"}}